Clinical Trials Logo
  1. Home
  2. Necrotizing Fasciitis
  3. NCT00538577
  4. Details
NCT00538577 Clinical Trial

Outcome and Related Factors of Necrotizing Fasciitis of the Limb

Necrotizing Fasciitis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00538577
Other study ID # 86-03-30-6110
Secondary ID
Status Completed
Phase N/A
First received September 30, 2007
Last updated October 4, 2009
Start date September 2007
Est. completion date September 2009

Study information
Verified date October 2009
Source Tehran University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Observational

Clinical Trial Summary

Soft tissue necrotizing fasciitis of limbs are lethal infections and associated with high morbidity and mortality rates. The purpose of this study is to determine the clinical manifestations and factors affected the treatment outcome to predict the prognosis and make timely decision for appropriate management and prevent limb loss.

Description:

Patients that are admitted to hospital with the diagnosis of necrotizing fasciitis of a limb will be entered to this study. A questionnaire will be completed for each patient included demographic data, admission and diagnosis date, treatment onset, medical history for diabetes mellitus, HIV infection, use of immunosuppressor drugs, peripheral vascular disease, cancer, renal disease, intravenous drug abuse, and disease outcome that can be recovery, amputation or death.

Recruitment information / eligibility
Status Completed
Enrollment 25
Est. completion date September 2009
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Necrotizing fasciitis of the limb

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Iran, Islamic Republic of Operative Theater of Orthopedic Surgery Department- Imam Khomeini Hospital Tehran

Sponsors (1)
Lead Sponsor Collaborator
Tehran University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

See also
  Status Clinical Trial Phase
Recruiting NCT05116956 - SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
Completed NCT04091672 - RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction N/A
Completed NCT01731483 - Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections
Completed NCT01139112 - Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features N/A
Recruiting NCT02169128 - Severe Soft Tissue Infections: Perspectives of Patients and Significant Others
Completed NCT01790698 - Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
Completed NCT02501382 - Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Completed NCT02180906 - Biomarkers in Patients With Flesh-eating Bacterial Infections N/A
Completed NCT02469857 - Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections Phase 3
Terminated NCT00353275 - Hyperglycemia in Surgical Infections N/A
Recruiting NCT06073301 - AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF Phase 4
Completed NCT02111161 - Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Phase 2